fenton's reagent has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertini, A; Bellei, C; Casella, L; Engelen, M; Sarna, T; Szewczyk, G; Zadlo, A; Zareba, M; Zecca, L; Zucca, FA | 1 |
| Kell, DB | 1 |
1 review(s) available for fenton's reagent and Parkinson Disease
| Article | Year |
|---|---|
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.
Topics: Alzheimer Disease; Anti-Bacterial Agents; Apoptosis; Humans; Huntington Disease; Hydrogen Peroxide; Hydroxyl Radical; Iron; Iron Chelating Agents; Ligands; Oxidative Stress; Parkinson Disease; Prion Diseases; Systems Biology | 2010 |
1 other study(ies) available for fenton's reagent and Parkinson Disease
| Article | Year |
|---|---|
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
Topics: Aged; Aged, 80 and over; Aging; Female; Humans; Hydrogen Peroxide; Iron; Iron Overload; Male; Melanins; Middle Aged; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Substantia Nigra | 2008 |